Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents

Gene Therapy

Volumn 20, Issue 11, 2013, Pages 1042-1052

  Kang, S ^a   Lu, K ^a   Leelawattanachai, J ^a   Hu, X ^a   Park, S ^a   Park, T ^a   Min, I M ^b   Jin, M M ^a,b  

^a Dongguk University   (South Korea)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ICAM 1; inflammation; integrin LFA 1; targeted gene delivery; virus mimetic polyplex particles

Indexed keywords

ASPARTIC ACID; CRE RECOMBINASE; GLUTAMIC ACID; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NUCLEIC ACID; PEPTIDE; POLYANIONIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL KILLING; CELL VIABILITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIGAND BINDING; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; RECEPTOR BINDING; VIRUS MIMETIC POLYPLEX PARTICLE; VIRUS PARTICLE; ZETA POTENTIAL;

ANIMALS; BIOMIMETIC MATERIALS; CELL LINE, TUMOR; FEMALE; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED BALB C; POLYETHYLENEIMINE; VIRION;

EID: 84887441569     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.29     Document Type: Article

References (54)

1. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010; 363: 355-364.
2. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K et al. Effect of gene therapy on visual function in Lebers congenital amaurosis. N Engl J Med 2008; 358: 2231-2239.
3. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342-347.
4. Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S et al. Dystrophin immunity in Duchennes muscular dystrophy. N Engl J Med 2010; 363: 1429-1437.
5. Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 2011; 477: 99-102.
6. McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2004; 350: 913-922.
7. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
8. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
9. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006; 114: 100-109.
10. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18: 33-37.
11. Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasi F et al. Stability of PEIDNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. J Control Release 2001; 76: 169-181.
12. Staprans I, Felts JM. Isolation and characterization of glycosaminoglycans in human plasma. J Clin Invest 1985; 76: 1984-1991.
13. Ruponen M, Yla-Herttuala S, Urtti A. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies. Biochim Biophys Acta 1999; 1415: 331-341.
14. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008; 134: 577-586.
15. Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 2008; 319: 627-630.
16. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005; 23: 709-717.
17. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010; 464: 1067-1070.
18. Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy. Nat Rev Genet 2007; 8: 573-587.
19. Maheshri N, Koerber JT, Kaspar BK, Schaffer DV. Directed evolution of adenoassociated virus yields enhanced gene delivery vectors. Nat Biotechnol 2006; 24: 198-204.
20. Douglas JT, Rogers BE, Rosenfeld ME, Michael SI, Feng M, Curiel DT. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996; 14: 1574-1578.
21. Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysinecondensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481-8487.
22. Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Therapy 1999; 6: 138-145.
23. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Therapy 1999; 6: 595-605.
24. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990; 87: 3410-3414.
25. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
26. Sadeqzadeh E, Rahbarizadeh F, Ahmadvand D, Rasaee MJ, Parhamifar L, Moghimi SM. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells. J Control Release 2011; 156: 85-91.
27. Somiya M, Yoshimoto N, Iijima M, Niimi T, Dewa T, Jung J et al. Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles. Bioorg Med Chem 2012; 20: 3873-3879.
28. Hildebrandt IJ, Iyer M, Wagner E, Gambhir SS. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Therapy 2003; 10: 758-764.
29. Kunath K, von Harpe A, Fischer D, Kissel T. Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Release 2003; 88: 159-172.
30. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999; 60: 149-160.
31. Sonawane ND, Szoka Jr FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003; 278: 44826-44831.
32. Akinc A, Thomas M, Klibanov AM, Langer R. Exploring polyethylenimine- mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005; 7: 657-663.
33. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
34. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-Associated antigen 1 (LFA-1). Cell 1987; 51: 813-819.
35. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
36. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med (Berl) 1996; 74: 13-33.
37. Tomassini JE, Graham D, DeWitt CM, Lineberger DW, Rodkey JA, Colonno RJ. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1989; 86: 4907-4911.
38. Grunert HP, Wolf KU, Langner KD, Sawitzky D, Habermehl KO, Zeichhardt H. Internalization of human rhinovirus 14 into HeLa and ICAM-1-transfected BHK cells. Med Microbiol Immunol 1997; 186: 1-9.
39. Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 2003; 116(Pt 8): 1599-1609.
40. Jin M, Song G, Carman CV, Kim YS, Astrof NS, Shimaoka M et al. Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci USA 2006; 103: 5758-5763.
41. Park S, Kang S, Veach AJ, Vedvyas Y, Zarnegar R, Kim JY et al. Self-Assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions. Biomaterials 2010; 31: 7766-7775.
42. Kang S, Park T, Chen X, Dickens G, Lee B, Lu K et al. Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery. Biomaterials 2011; 32: 3487-3498.
43. Chen X, Wong R, Khalidov I, Wang AY, Leelawattanachai J, Wang Y et al. Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation. Biomaterials 2011; 32: 7651-7661.
44. Huth JR, Olejniczak ET, Mendoza R, Liang H, Harris EA, Lupher Jr. ML et al. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-Associated antigen 1 ligand binding. Proc Natl Acad Sci USA 2000; 97: 5231-5236.
45. Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ et al. The crystal structure of diphtheria toxin. Nature 1992; 357: 216-222.
46. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
47. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med 1999; 340: 115-126.
48. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
49. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995; 96: 549-557.
50. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
51. Cabantous S, Terwilliger TC, Waldo GS. Protein tagging and detection with engineered self-Assembling fragments of green fluorescent protein. Nat Biotechnol 2005; 23: 102-107.
52. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997; 124: 2691-2700.
53. Cudre-Mauroux C, Occhiodoro T, Konig S, Salmon P, Bernheim L, Trono D. Lentivector- mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum Gene Ther 2003; 14: 1525-1533.
54. Zou K, Yuan Z, Yang Z, Luo H, Sun K, Zhou L et al. Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol 2009; 11: 631-636.